The lack of an effective animal model has been a major obstacle in attempts to define the role of humoral and cellular immune responses in protection against flavivirus infection. We have used F1 hybrid mice (BALB/c × C3H/RV) that are heterozygous for the flavivirus resistance allele Flvr and show reduced virus replication in the brain after intracerebral inoculation. F1 hybrid mice challenged by intracerebral inoculation with Murray Valley encephalitis (MVE) virus developed encephalitis 2–3 days later than a genetically susceptible strain (BALB/c) but showed a similar mortality rate. This delay in the onset of disease provided more opportunity for virus clearance by primed immune responses. Using F1 hybrid mice we were able to demonstrate protective immunity induced by structural and non-structural proteins of MVE virus by immunization with pure NS1 protein or recombinant vaccinia viruses that expressed various regions of the MVE genome. These constructs included VV-STR (C-prM-E-NS1-NS2A), VV-ΔC (prM-E-NS1-NS2A) and VV-NS1 (NS1-NS2A). VV-ΔC vaccinated mice were completely protected (100% survival) from challenge with 1000 infectious units of MVE virus, while mice inoculated with VV-STR, VV-NS1 or pure NS1 were partially protected (40%, 47% and 85% respectively). Analysis of prechallenge sera and in vivo depletion studies revealed that the solid protection induced by VV-ΔC was mediated by neutralizing antibody to the E protein and did not require a CD8+ T cell response. The partial protection provided by VV-STR, VV-NS1 and pure NS1 occurred after induction of antibody to NS1. However, depletion of CD8+ cells prior to virus challenge ablated the protection provided by VV-NS1 indicating some requirement for class I restricted cytotoxic T cells.
BoyleD. B.1979; Comparative studies of two related Australian flaviviruses, Murray Valley encephalitis and Kunjin. PhD thesis, Australian National University; Canberra, Australia:
CobboldS. P.,
JayasuriyaA.,
NashA.,
ProsperoT. D.,
WaldmannH.1984; Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548–551
DalgarnoL.,
TrentD. W.,
StraussJ. H.,
RiceC. M.1986; Partial nucleotide sequence of the Murray Valley encephalitis virus genome. Comparison of the encoded polypeptides with yellow fever virus structural and non-structural proteins. Journal of Molecular Biology 187:309–323
GouldE. A.,
BuckleyA.,
BarrettA. D. T.,
CammackN.1986; Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67:591–595
GrossbergS. E.,
SchererW. F.1966; The effect of age, virus dose and route of inoculation on unapparent infection in mice with Japanese encephalitis virus. Procedures of the Society of Experimental Biology and Medicine 123:118–124
HallR. A.,
BurgessG. W.,
KayB. H.1988; Type-specific monoclonal antibodies produced to proteins of Murray Valley encephalitis virus. Immunology and Cell Biology 66:51–56
HallR. A.,
KayB. H.,
BurgessG. W.,
ClancyP.,
FanningI. D.1990; Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. Journal of General Virology 71:2923–2930
HallR. A.,
CoelenR. J.,
MackenzieJ. S.1991; Immunoaffinity purification of the NS1 protein of Murray Valley encephalitis virus: selection of the appropriate ligand and optimal conditions for elution. Journal of Virological Methods 32:11–20
HawkesR. A.,
RoehrigJ. T.,
HuntA. R.,
MooreG. A.1988; Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. Journal of General Virology 69:1105–1109
JacobsS. C.,
StephensonJ. R.,
WilkinsonG. W. G.1994; Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1. Journal of General Virology 75:2399–2402
Kimura-KurodaJ.,
YasuiK.1988; Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. Journal of Immunology 141:3606–3610
KonishiE.,
PincusS.,
PaolettiE.,
ShopeR. E.,
BurrageT.,
MasonP. W.1992; Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188:714–720
KuraneL.,
MeagerA.,
EnnisF. A.1989; Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. Journal of Experimental Medicine 170:763–775
KuraneI.,
BrintonM. A.,
SamsonA. L.,
EnnisF. A.1991; Dengue virus-specific, human CD4+ CDS cytotoxic T cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. Journal of Virology 65:1825–1828
LevineB.,
HardwickJ. M.,
TrappB. D.,
CrawfordT. O.,
BollingerR. C.,
GriffinD. E.1991; Antibody-mediated clearance of alphavirus infection from neurones. Science 254:856–860
LobigsM.1993; Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proceedings of the National Academy of Sciences, USA 90:6218–6222
LobigsM.,
ArthurC. E.,
MuellbacherA.,
BlandenR. V.1994; The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T cell peptide determinants. Virology 202:195–201
MackettM.,
SmithG. L.,
MossB.1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
MasonP. W.,
PincusS.,
FournierM. J.,
MasonT. L.,
ShopeR. E.,
PaolettiE.1991; Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294–305
MonathT. P.1986; Pathobiology of the flaviviruses. In The Togaviridae and Flaviviridae pp. 375–440 Edited by
SchlesingerS.,
SchlesingerM.
New York: Plenum Press;
ParrishC. R.,
CoiaG.,
HillA.,
MuellbacherA.,
WestawayE. G.,
BlandenR. V.1991; Preliminary analysis of murine cytotoxic T cell responses to the proteins of the flavivirus Kunjin using vaccinia virus expression. Journal of General Virology 72:1645–1653
SangsterM. Y.,
UrosevicN.,
MansfieldJ. P.,
MackenzieJ. S.,
ShellamG. R.1994; Mapping the Flv locus controlling resistance to flaviviruses on mouse chromosome 5. Journal of Virology 68:448–452
SchlesingerJ. J.,
BrandrissM. W.,
PutnakJ. R.,
WalshE. E.1990; Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. Journal of General Virology 71:593–599
SchlesingerJ. J.,
FoltzerM.,
ChapmanS.1993; The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192:132–141